Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin Supplementation and Oxidative DNA Damage Repair Capacity Among Night Shift Workers: a Randomized Placebo-controlled Trial

NCT03945955 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT03945955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03945955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin Supplementation and Oxidative DNA Damage Repair Capacity Among Night Shift Workers: a Randomized Placebo-controlled Trial
Lead sponsor
University of British Columbia
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2022
Completion date
November 1, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dna damage repair deficiency, oxidative stress, sleep quality